Cardiovascular events associated with nicorandil administration prior to primary percutaneous coronary intervention in patients with acute ST-segment elevated myocardial infarction: a systematic review and meta-analysis.

Conclusion: Nicorandil administration at the time of primary PCI is associated with reduced MACE (both short- and long-term) and no-reflow phenomenon in patients with STEMI. PMID: 31117845 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31117845?dopt=Abstract

Source: Expert Opinion on Drug Safety - May 24, 2019 Category: Drugs & Pharmacology Tags: Expert Opin Drug Saf Source Type: research